NL195096C - Farmaceutisch preparaat dat ciclosporine bevat in een voor topische toepassing karakteristieke vorm en/of samenstelling. - Google Patents

Farmaceutisch preparaat dat ciclosporine bevat in een voor topische toepassing karakteristieke vorm en/of samenstelling. Download PDF

Info

Publication number
NL195096C
NL195096C NL8803125A NL8803125A NL195096C NL 195096 C NL195096 C NL 195096C NL 8803125 A NL8803125 A NL 8803125A NL 8803125 A NL8803125 A NL 8803125A NL 195096 C NL195096 C NL 195096C
Authority
NL
Netherlands
Prior art keywords
iii
ciclosporin
preparation
topical application
treatment
Prior art date
Application number
NL8803125A
Other languages
English (en)
Dutch (nl)
Other versions
NL8803125A (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8803125A publication Critical patent/NL8803125A/nl
Application granted granted Critical
Publication of NL195096C publication Critical patent/NL195096C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NL8803125A 1987-12-21 1988-12-21 Farmaceutisch preparaat dat ciclosporine bevat in een voor topische toepassing karakteristieke vorm en/of samenstelling. NL195096C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US13623087 1987-12-21
US17261388A 1988-03-24 1988-03-24
US17261388 1988-03-24
US21254888A 1988-06-28 1988-06-28
US21254888 1988-06-28

Publications (2)

Publication Number Publication Date
NL8803125A NL8803125A (nl) 1989-07-17
NL195096C true NL195096C (nl) 2004-02-09

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8803125A NL195096C (nl) 1987-12-21 1988-12-21 Farmaceutisch preparaat dat ciclosporine bevat in een voor topische toepassing karakteristieke vorm en/of samenstelling.

Country Status (27)

Country Link
JP (1) JPH0791316B2 (da)
KR (1) KR100188305B1 (da)
AT (1) AT403163B (da)
AU (1) AU626274B2 (da)
BE (1) BE1002665A4 (da)
CA (1) CA1341396C (da)
CH (1) CH677926A5 (da)
CY (1) CY1799A (da)
DE (1) DE3843054C2 (da)
DK (1) DK175220B1 (da)
ES (1) ES2012580A6 (da)
FI (1) FI89065C (da)
FR (1) FR2624863B1 (da)
GB (1) GB2211848B (da)
GR (1) GR1002486B (da)
HK (1) HK102894A (da)
HU (1) HU203564B (da)
IE (1) IE62006B1 (da)
IL (1) IL88719A0 (da)
IT (1) IT1235356B (da)
LU (1) LU87409A1 (da)
MY (1) MY103943A (da)
NL (1) NL195096C (da)
NO (1) NO177228C (da)
NZ (1) NZ227384A (da)
SE (1) SE503174C2 (da)
SG (1) SG99494G (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
ES2177652T3 (es) 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
KR20050084502A (ko) 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CN100548271C (zh) 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
BR112013030554B1 (pt) * 2011-05-27 2020-12-15 Allergan, Inc. Forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma
RU2641963C2 (ru) * 2011-11-15 2018-01-23 Аллерган, Инк. Взвеси циклоспорина а формы 2
US20130123194A1 (en) * 2011-11-15 2013-05-16 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
CA2856034C (en) * 2011-11-15 2017-12-12 Allergan, Inc. Cyclosporin a form 2 and method of making same
US8785394B2 (en) * 2011-11-15 2014-07-22 Allergan, Inc. Sustained action formulation of cyclosporin form 2
TW202430537A (zh) * 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (da) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
NZ227384A (en) 1991-09-25
DK705488A (da) 1989-06-22
CH677926A5 (da) 1991-07-15
LU87409A1 (fr) 1989-07-07
DK175220B1 (da) 2004-07-12
JPH01211598A (ja) 1989-08-24
FR2624863A1 (fr) 1989-06-23
IT8848690A0 (it) 1988-12-20
SE8804570D0 (sv) 1988-12-19
KR100188305B1 (ko) 1999-06-01
BE1002665A4 (fr) 1991-04-30
GR1002486B (el) 1996-12-09
GR880100850A (el) 1994-03-31
MY103943A (en) 1993-10-30
HK102894A (en) 1994-09-30
IT1235356B (it) 1992-06-30
CY1799A (en) 1995-02-17
CA1341396C (en) 2002-11-05
NL8803125A (nl) 1989-07-17
AT403163B (de) 1997-11-25
ES2012580A6 (es) 1990-04-01
JPH0791316B2 (ja) 1995-10-04
FR2624863B1 (fr) 1991-04-26
NO885625D0 (no) 1988-12-19
GB2211848B (en) 1991-11-06
ATA309588A (de) 1997-04-15
FI885869A0 (fi) 1988-12-19
FI89065C (fi) 1993-09-30
SE8804570L (sv) 1989-06-22
DE3843054A1 (de) 1989-07-27
AU626274B2 (en) 1992-07-30
DK705488D0 (da) 1988-12-19
NO885625L (no) 1989-06-22
SE503174C2 (sv) 1996-04-15
IL88719A0 (en) 1989-07-31
IE62006B1 (en) 1994-12-14
AU2705588A (en) 1989-06-22
FI885869L (fi) 1989-06-22
FI89065B (fi) 1993-04-30
IE883779L (en) 1989-06-21
KR890009975A (ko) 1989-08-05
SG99494G (en) 1994-10-28
HUT49893A (en) 1989-11-28
NO177228B (no) 1995-05-02
DE3843054C2 (de) 2003-08-21
NO177228C (no) 1995-08-09
HU203564B (en) 1991-08-28
GB8829556D0 (en) 1989-02-08
GB2211848A (en) 1989-07-12

Similar Documents

Publication Publication Date Title
AU626274B2 (en) New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use.
DE69414840T2 (de) Akzeptabele pharmazeutische zusammensetzung enthaltend einen alkohol und einen hydrophalischen wirkstoff
NL194781C (nl) Farmaceutisch preparaat voor orale toediening dat een cyclosporine bevat.
ES2565317T3 (es) Composición tópica para el cuidado de la piel
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
HUT77283A (hu) Egyszerű összetételű, a hatóanyagot biológiailag jól hozzáférhetően tartalmazó, orális alkalmazásra szánt új ciklosporinkészítmény és eljárás az előállítására
JP2012006931A (ja) 疎水性治療剤の改善された送達のための組成物および方法
US5952383A (en) Pharmaceutical composition for oral delivery
NL195094C (nl) Farmaceutische preparaat dat opgelost cyclosporine bevat en werkwijze voor de bereiding daarvan.
RU2174394C2 (ru) Фармацевтические композиции, содержащие производные n-сульфонилиндолина
JP4430889B2 (ja) 難溶性素材含有皮膚外用製剤
JPH04159227A (ja) 消炎鎮痛クリーム剤組成物
PL155712B1 (en) Method of obtaining novel crystalline form of cyclosporin
JP3626482B2 (ja) 微粉化された尿素を含んでなる水を含まないスキンケア配合物およびその製造方法
JP2516477B2 (ja) 皮膚の血行不良に起因する疾患の治療剤
HU212727B (en) Process for producing pharmaceutical compositions in form of microemulsion-prae-concentrate or microemulsion containing cyclosporin(s) as active component
JPH0390022A (ja) 皮膚疾患治療用外用剤

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG